Opseu Pension Plan Trust Fund Alnylam Pharmaceuticals, Inc. Transaction History

Opseu Pension Plan Trust Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$128.63 - $176.89 $592,984 - $815,462	-4,610 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$126.83 - $175.69 $11,922 - $16,514	94 Added 2.08%	4,610 $659,000
Q4 2020 Feb 11, 2021	BUY	$122.97 - $147.0 $3,689 - $4,410	30 Added 0.67%	4,516 $582,000
Q3 2020 Nov 09, 2020	SELL	$121.19 - $165.49 $42,052 - $57,425	-347 Reduced 7.18%	4,486 $663,000
Q2 2020 Aug 10, 2020	BUY	$104.21 - $156.44 $503,646 - $756,074	4,833 New	4,833 $715,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Opseu Pension Plan Trust Fund, based on Form 13F filings with the SEC.

Stay updated on Opseu Pension Plan Trust Fund with notifications on news.